Cardlytics Q3 revenue $72.7M (+12% YoY); net income $6.3M vs loss; Q4 guidance $80-90M

Cardlytics, Inc.

2022-Q3 EPS reported -$2.60 revenue$216,039,000

Revenue $72.7M (+12% YoY); gross profit $26.0M (+6% YoY).
Net income attributable to common stockholders $6.3M ($0.19 diluted EPS) vs net loss $(44.5M) in Q3 2021.
Non-GAAP net loss $(16.5)M ($(0.50) per share) widened from $(11.0)M loss.
Adjusted EBITDA loss $(12.7)M vs $(5.2)M loss in prior year.
Q4 guidance: revenue $80-90M, adjusted contribution $38-44M, billings $120-132M.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Cardlytics, Inc. reported third quarter ended September 30, 2022 results: revenue $72.7 million, net income $6.3 million, EPS $0.19 per diluted share. Guidance initiated.

Period: third quarter ended September 30, 2022
Revenue: $72.7 million
Net income: $6.3 million
EPS: $0.19 per diluted share
Guidance: initiated
Result: reported results

Exact text from the filing

for 2023. We are focused on taking the necessary steps to ensure we can control our destiny and achieve our long-term goals.” Third Quarter 2022 Financial Results • Revenue was $72.7 million, an increase of 12% year-over-year, compared to $65.0 million in the third quarter of 2021. • Billings, a non-GAAP metric, was $110.4 million, an increase of 12% year-over-year,

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Cardlytics, Inc. filing history →

Source: SEC EDGAR

accession 0001666071-22-000132

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.